Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
about
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomasmRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete.Cancer stem cells: the final frontier for glioma virotherapy.Telomerase as a therapeutic target for malignant gliomas.p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: A retrospective study.MMP-9 silencing regulates hTERT expression via β1 integrin-mediated FAK signaling and induces senescence in glioma xenograft cells.Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomasExperimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.Potential clinical role of telomere length in human glioblastoma.PinX1-siRNA/mPEG-PEI-SPION combined with doxorubicin enhances the inhibition of glioma growthPrognostic markers of astrocytoma: how to predict the unpredictable?Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines.Suramin increased telomerase activity in the c6 glioma/wistar experimental brain tumor model.The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth.Amphiregulin induces proliferative activities in osseous dysplasia.Progression of astrocytomas and meningiomas: an evaluation in vitro.Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study.
P2860
Q28397245-2D80B7D1-ED88-4796-8052-3367919301A2Q30486814-AD645A0A-1AA0-4F29-8966-1930687C66F8Q34516701-7F015BB6-7F2A-4A93-A68F-8A0975BB3BAEQ34535709-1E2FE014-CD08-4B34-8A26-D6BC85D538ADQ34583151-58CC417E-AE92-42B2-B3B0-942B3FF90BA7Q35250688-4147363E-749F-4008-BB3C-555AF1D60E30Q36649125-C3B414D3-84A1-4F81-94F5-159CAB0F8350Q36756809-A7119B17-1BF7-49B9-A5A9-4918143FFC6EQ37058454-024FAA68-BAE0-4486-AD4D-3B030EB385D6Q37710054-0C806C53-2B53-4E4C-9562-F37CDD085CA0Q38089921-865BEFFC-CE4B-41F8-BCF3-50BD5D081BDFQ39144903-DB249BD0-8362-4947-AFB9-5B678053E779Q39524740-AA085EA7-9498-4F73-916B-B7BDCA0F598DQ39756110-FDAA0821-EA28-42AC-B789-52860394C19EQ39827319-4FDBA042-49E3-43BB-A728-D362D7216918Q48308391-6776CDF7-407E-4ADC-A975-41272689E68CQ54606951-E7C6A9F1-8333-4130-BD79-63A6EC50363D
P2860
Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Telomerase activity in primary ...... novel molecular tumor marker.
@en
Telomerase activity in primary ...... novel molecular tumor marker.
@nl
type
label
Telomerase activity in primary ...... novel molecular tumor marker.
@en
Telomerase activity in primary ...... novel molecular tumor marker.
@nl
prefLabel
Telomerase activity in primary ...... novel molecular tumor marker.
@en
Telomerase activity in primary ...... novel molecular tumor marker.
@nl
P2093
P1476
Telomerase activity in primary ...... novel molecular tumor marker.
@en
P2093
P304
P356
10.3171/JNS.2000.93.4.0618
P407
P577
2000-10-01T00:00:00Z